Kura Oncology Inc diskutieren
Kura Oncology Inc
WKN: A143UH / Name: Kura Oncology / Aktie / Biotechnologie & medizinische Forschung / Small Cap /
17,29 €
-0,20 %
SecteurRecherche biotechnologique et médicale Agenda 05/11 Publication de résultats
Provides biopharmaceutical services
Kura Oncology, Inc. operates as a clinical-stage biopharmaceutical company which engages in the research and development of medicines for the treatment of cancer.
Its pipeline includes Tipifarnib which is a Farnesyl transferase inhibitor for HRAS Mutant Solid Tumors, Chronic Myelomonocytic Leukemia; KO-947 which is an ERK inhibitor for MAPK Pathway Tumors; and KO-539 which is a Menin MLL inhibitor for acute leukemias.
The company was founded by Troy E. Wilson, Yi Liu, Pingda Ren and Antonio Gualberto on August 22, 2014 and is headquartered in La Jolla, CA.
Kura Oncology, Inc. operates as a clinical-stage biopharmaceutical company which engages in the research and development of medicines for the treatment of cancer.
Its pipeline includes Tipifarnib which is a Farnesyl transferase inhibitor for HRAS Mutant Solid Tumors, Chronic Myelomonocytic Leukemia; KO-947 which is an ERK inhibitor for MAPK Pathway Tumors; and KO-539 which is a Menin MLL inhibitor for acute leukemias.
The company was founded by Troy E. Wilson, Yi Liu, Pingda Ren and Antonio Gualberto on August 22, 2014 and is headquartered in La Jolla, CA.
Nombre d'employés : 31 personnes.
(Vom Mitglied beendet)
klostergang stimmt der Buy-Einschätzung der institutionellen Analysten zu
klostergang stimmt am 18.01.2019 der Buy-Einschätzung der institutionellen Analysten mit dem Kursziel 27.43$ zu.
tamam stimmt der Buy-Einschätzung der institutionellen Analysten zu
tamam stimmt am 22.01.2019 der Buy-Einschätzung der institutionellen Analysten mit dem Kursziel 27.43$ zu.
(Stop Loss Kurs erreicht)
Buy Kura Oncology Inc
Kursziel geändert auf 13,0
Buy Kura Oncology Inc
Buy Kura Oncology Inc
Kursziel geändert auf 16,0
Sell Kura Oncology Inc
Buy Kura Oncology Inc
Buy Kura Oncology Inc
Buy Kura Oncology Inc
Buy Kura Oncology Inc
Sell Kura Oncology Inc
Buy mit Kursziel 21,0
Buy Kura Oncology Inc
Kursziel geändert auf 35,0
Buy Kura Oncology Inc
Neueste Beiträge
Lokrim in Capricor Therapeutics Inc diskutieren